← Back to Search

IQOS Use for Smoking Cessation (IQOS Trial)

Phase < 1
Waitlist Available
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Willing to use study provided IQOS devices and HeatSticks during 2 laboratory visits and throughout study participation
Male and female smokers between 18 and 65 years of age who self-report smoking at least 5 cigarettes (menthol and/or non-menthol) per day for at least the last 12 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 21 days
Awards & highlights

IQOS Trial Summary

This trial will evaluate how well the IQOS device works in helping smokers quit cigarettes. 100 smokers will use the IQOS for 14 days instead of cigarettes and be monitored for success in quitting.

Who is the study for?
This trial is for English-speaking smokers aged 18-65 who smoke at least 5 cigarettes daily for the past year, are not trying to quit in the next month but are interested within six months. They must live locally and agree to use IQOS instead of cigarettes during the study. Pregnant women, heavy drinkers, those with serious diseases or mental health issues like major depression or schizophrenia, substance abuse history, or using other nicotine products aren't eligible.Check my eligibility
What is being tested?
The study tests if switching from regular cigarettes to an IQOS device affects smoking behavior over two weeks among 100 participants. It measures how often they smoke before and after getting IQOS and looks into what factors predict whether someone fully switches to this alternative.See study design
What are the potential side effects?
While specific side effects of IQOS use compared to traditional cigarette smoking aren't detailed here, generally users might experience throat irritation or coughing as common reactions when transitioning from conventional smoking methods.

IQOS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am willing to use the provided IQOS devices and HeatSticks for the study.
Select...
I am between 18 and 65 years old and have smoked at least 5 cigarettes daily for the past year.

IQOS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~21 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 21 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cigarette consumption
Secondary outcome measures
Motivation for smoking cessation

IQOS Trial Design

1Treatment groups
Experimental Treatment
Group I: IQOSExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
1,992 Previous Clinical Trials
42,875,259 Total Patients Enrolled
8 Trials studying Tobacco Use
3,929 Patients Enrolled for Tobacco Use

Media Library

IQOS Clinical Trial Eligibility Overview. Trial Name: NCT05076708 — Phase < 1
Tobacco Use Research Study Groups: IQOS
Tobacco Use Clinical Trial 2023: IQOS Highlights & Side Effects. Trial Name: NCT05076708 — Phase < 1
IQOS 2023 Treatment Timeline for Medical Study. Trial Name: NCT05076708 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any slots still available to take part in the experiment?

"Clinicaltrials.gov attests that this clinical trial is ongoing, having been inaugurated on August 26th 2021 and last revised on September 29th 2022."

Answered by AI

How many individuals have registered for the trial thus far?

"Affirmative. Clinicaltrials.gov documents that this medical study is accepting new patients - the trial was first posted on August 26th 2021 and has seen its most recent update on September 29th 2022. Across one site, a total of 100 participants are required for enrollment in the study."

Answered by AI

Are elderly participants eligible for this clinical investigation?

"Individuals with ages between 18 and 65 may be eligible to participate in this research experiment."

Answered by AI

Is enrollment in this research protocol open to me?

"This medical research endeavour is searching for 100 individuals aged 18-65 who currently smoke cigarettes, with a minimum of 5 per day in the last 12 months. Eligibility also necessitates being male or female, disinclined to quit smoking within 30 days and desirous to do so in the following 6 months, as well as having no plans on relocating from their current residence during the study's duration."

Answered by AI

Who else is applying?

What site did they apply to?
University of Pennsylvania
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

It looks interesting and possibly helpful.
PatientReceived 1 prior treatment
~28 spots leftby Mar 2025